U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 21 - 30 of 34

Checklist of Evidence-Based Recommendations for Caring for Pregnant Women with Opioid Use Disorder (PDF - 181 KB)

The following checklist intends to support health care teams in providing evidence-based recommendations for treating pregnant and postpartum patients with OUD. The checklist is divided into five sections, sequenced by timing of presentation to care.

Format
Other
Audience
Behavioral Health Providers
Medical Providers
Other Team Members
Source
Massachusetts Child Psychiatry Access Program (MCPAP) for Moms
Year
Resource Type
PDF

FDA Public Workshop on Opioid Prescriber Education

This was a two-day virtual public workshop (which can now be re-watched) that convened regulators, clinical researchers, providers, patient advocates, and other stakeholders to exchange information and obtain input by discussing prescriber education's potential role in alleviating the evolving opioid and substance use crisis.
Format
Webinar/Video
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Communities
Policymakers and Payers
Source
Duke-Margolis Center for Health Policy / Food and Drug Administration (FDA)
Year
Resource Type
Video

Helping People Who Use Opioids and Stimulants (PDF - 212 KB)

This brief describes research documenting the added challenges stimulant use contributes to those who use opioids and patient-centered approaches for working with people who use stimulants that are enrolled in medication treatment for opioid use disorder.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Communities
Policymakers and Payers
States
Source
Addictions, Drug & Alcohol Institute, University of Washington
Year
Resource Type
PDF

Opioid Use in the Context of Polysubstance Use: Research Opportunities for Prevention, Treatment, and Sustained Recovery - Executive Summary (PDF - 199 KB)

A summary of a workshop from the National Institutes of Health (NIH) HEAL (Helping to End Addiction Long-Term) Initiative, discussing opioid use in the context of polysubstance use.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Policymakers and Payers
Source
National Institute on Drug Abuse (NIDA)
Year
Resource Type
PDF

Opioids and Stimulants: What Are They and How Are People Using Them (PDF - 324 KB)

This brief reviews opioid and stimulant trends in availability, use, and impacts; compares opioids and stimulants in terms of drug effects and motivations for use; and examines the factors that drive co-use.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Families
Communities
Policymakers and Payers
States
Source
Addictions, Drug & Alcohol Institute, University of Washington
Year
Resource Type
PDF

Polysubstance Use Disorders in Four State Medicaid Programs (PDF - 154 KB)

This brief examines the prevalence of diagnoses of polysubstance use disorders, describes the characteristics of Medicaid enrollees with polysubstance use disorders, and compares the mental health and medical comorbidities based on the number of unique substance use disorders.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Academy Health
Year
Resource Type
PDF

Safe Use of Benzodiazepines: Clinical, Regulatory, and Public Health Perspectives

This two-day public workshop convened regulators, academic researchers, clinicians, patient advocates, and other stakeholders to share information underlying this action and gather input related to the safe use of benzodiazepines.
Format
Webinar/Video
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Communities
Policymakers and Payers
Source
Duke-Margolis Center for Health Policy / Food and Drug Administration (FDA)
Year
Resource Type
Video

2019 National Survey On Drug Use And Health: Women (PDF - 4.5 MB)

These reports and detailed tables present estimates from the 2019 National Survey on Drug Use and Health (NSDUH), specifically pertaining to substance use among women.

Format
Report/Paper/Issue Brief
Audience
Policymakers and Payers
States
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
PDF

Common Comorbidities with Substance Use Disorders Research Report (PDF - 192.94 KB)

This research report provides information on the state of the science in the comorbidity of substance use disorders with mental illness and physical health conditions.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
National Institute on Drug Abuse (NIDA)
Year
Resource Type
PDF

Polysubstance Use During Pregnancy

The official CDC page on research pertaining to polysubstance use during pregnancy, suggesting ways to help reduce substance exposure during pregnancy and improve the health of women and their children.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Source
Centers for Disease Control and Prevention (CDC)
Year
Resource Type
Web Page